Product Code: GVR-1-68038-817-6
Tourniquet Systems Market Growth & Trends:
The global tourniquet systems market size is expected to reach USD 873.3 million by 2030, registering a CAGR of 7.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Growing incidence of industrial & road accidents and major falls has been a major factor driving market growth. In addition, rapid increase in the number of hospitals and surgical care centers has led to increased application of tourniquets.
Tourniquets are majorly used when hemorrhages cannot be controlled with direct pressure or selective clamping of bleeding vessels. Certain advantages in modern surgical tourniquet systems such as safety, accuracy, and reliability have resulted in the widespread adoption of these devices in orthopedic surgeries. Furthermore, technologically advanced tourniquet systems are now integrated with a wide range of pneumatic cuffs that help optimize the performance of the overall system. However, reusable cuffs might result in the transmission of infection, which would consequently raise hospital costs and may hinder the growth of the market during the forecast period.
Tourniquet Systems Market Report Highlights:
- The market study suggests that tourniquet cuffs dominated the market with the largest revenue share in 2022 owing to their increasing applications in orthopedics, trauma, and emergency settings.
- Amongst the application segments, hospitals occupied the largest share as they are effective in arresting life threatening external hemorrhage caused due to limb injury
- In addition, the non-institutional application segment tourniquet systems is expected to grow rapidly due to the potential application of tourniquets in military war settings.
- The Advanced Trauma Life Support (ATLS) recommends that "the judicious use of a pneumatic tourniquet may be helpful and lifesaving" in cases of major arterial hemorrhage caused by military wars
- North America dominated the market and accounted for the largest revenue share of 53.5% in 2022 owing to the presence of excellent healthcare infrastructure, rise in the number of road accidents, and increasing adoption of advanced tourniquet devices
- The Asia Pacific is expected to grow at the fastest CAGR of 8.7% over the forecast period. It will have one of the widest consumer base of tourniquets owing to the huge population, increasing industrial & road accidents, and commendable financial support from various governments.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Component
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Component outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Tourniquet Systems Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Tourniquet Systems Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Tourniquet Systems: Component Estimates & Trend Analysis
- 4.1. Tourniquet Systems Market: Key Takeaways
- 4.2. Tourniquet Systems Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Tourniquet Instrument
- 4.3.1. Tourniquet instrument market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Tourniquet Cuffs
- 4.4.1. Tourniquet cuffs market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Pneumatic
- 4.4.2.1. Pneumatic market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.2. Disposable
- 4.4.2.2.1 Disposable market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.3. Reusable
- 4.4.2.3.1 Reusable market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Non-Pneumatic
- 4.4.3.1. Non-pneumatic market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Tourniquet Systems Market: Application Estimates & Trend Analysis
- 5.1. Tourniquet Systems Market: Key Takeaways
- 5.2. Tourniquet Systems Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Hospitals
- 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Ambulatory Setting
- 5.4.1. Ambulatory setting market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Non-institutional Use
- 5.5.1. Non-institutional use market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Tourniquet Systems Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Tourniquet Systems Market by Region: Key Takeaways
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. South Africa
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Delfi Medical Innovations Inc.
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Zimmer Biomet
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Hammarplast Medical AB
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. VBM Medizintechnik GmbH
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Stryker
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Ulrich Medical
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Rudolf Riester GmbH
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. AneticAid
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives